Mountain rescue team help injured walker on Scafell Pike in Lake District
A MOUNTAIN rescue team was called out to help a man who had injured his knee.
The walker was unable to continue his journey on Scafell Pike, and Wasdale Mountain Rescue were brought in to assist him.
The team was called out on Wednesday, June 18, to the incident.
In a post on social media, Wasdale Mountain Rescue said: "The team was called on Wednesday afternoon by Cumbria Police.
"A walker had fallen and painfully injured his knee, making it impossible to continue further. He has also lost consciousness briefly but has since recovered.
"A full callout was made, and the team made their way to the location. Helimed 58 also responded but was unable to land close enough, so it was forced to abort.
"A medical assessment was made before transferring the walker carefully into the team stretcher.
"The long but routine carry was then completed without incident down to Brackenclose, where the walker was transferred into their own vehicle for onward transfer to the hospital.
"We wish the walker a very quick recovery and hope to see him back on the fells soon."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
Why nightmares could make you age faster and die sooner
Frequent nightmares are linked to premature ageing and increase the risk of an early death, according to a new study. Adults who report weekly nightmares are more than three times likely to die before the age of 70 compared to those who rarely or never experience them, researchers found. The study found nightmares to be a 'stronger predictor of premature death' than smoking, obesity, poor diet, and low physical activity. The scientists warned the findings should be treated as a 'public health concern', but said people can reduce nightmares by managing stress. The team, led by Dr Abidemi Otaiku of the UK Dementia Research Institute, and Imperial College London, analysed data from 2,429 children aged eight to 10 and 183,012 adults aged 26 to 86 over a period of 19 years. The research, presented at the European Academy of Neurology (EAN) Congress this month, found that nightmares disrupt both sleep quality and duration, which impairs the body's overnight cellular restoration and repair ability. The combined impacts of chronic stress and disrupted sleep are likely to contribute to the accelerated ageing of our cells and bodies. Dr Otaiku said, 'Our sleeping brains cannot distinguish dreams from reality. That's why nightmares often wake us up sweating, gasping for breath, and with our hearts pounding – because our fight-or-flight response has been triggered. This stress reaction can be even more intense than anything we experience while awake.' He said: 'Nightmares lead to prolonged elevations of cortisol, a stress hormone closely linked to faster cellular ageing. For those who frequently experience nightmares, this cumulative stress may significantly impact the ageing process.' He added: 'Given how common and modifiable nightmares are, they should be taken far more seriously as a public health concern.' Researchers found that children and adults who had frequent nightmares also exhibited faster ageing. This accounted for approximately 40 per cent of those who had a higher risk of early death. Dr Otaiku said this was the first study to show nightmares can predict faster biological ageing and earlier mortality, even after accounting for other health issues. Even monthly nightmares were linked to faster ageing and increased mortality compared to those who had no nightmares. and the links were consistent across all ages, sexes, ethnicities, and mental health statuses. 'The good news is that nightmares can be prevented and treated,' said Dr Otaiku. Simple measures, such as maintaining good sleep hygiene, managing stress, seeking treatment for anxiety or depression and not watching scary films can be effective in reducing nightmares, he said.
Yahoo
2 hours ago
- Yahoo
Can a Laser Replace MRI Scans? One Bold Experiment Says Yes
In a discovery that could reshape how we view and understand the human brain, researchers have successfully passed a laser beam through an entire human head. While it may sound like science fiction, this quiet milestone could pave the way for faster, cheaper, and noninvasive brain scans. The work comes from a team at the University of Glasgow, who set out to push the limits of functional near-infrared spectroscopy (fNIRS). This technology already offers a portable, low-cost way to monitor brain activity, but until now, it's only been able to peek a few centimeters beneath the skull. For anything deeper, expensive MRI machines have been the standard. That may be about to change. By boosting the power of the laser (within safe limits) and improving the light-collection setup, scientists managed to transmit photons from one side of the skull to the other. It worked on just one out of eight participants—a bald man with fair skin—but it proved something previously thought impossible: a beam of light can travel through the entire human head. The implications are huge. If refined, this technology could close the gap between inexpensive tools like EEG and high-resolution, high-cost MRI scans. In the future, diagnosing strokes, brain injuries, or tumors might not require hospital-grade equipment—just a small, light-based scanner. What made this breakthrough even more compelling was the way the light traveled. Instead of bouncing randomly through the skull, photons followed predictable paths, especially through more transparent areas like cerebrospinal fluid. That opens the door to more targeted imaging, where specific brain regions could be scanned with precision. To validate the experiment, researchers used 3D head models to predict photon movement and then compared the results to actual light data. The results aligned, adding credibility to what may one day be a revolutionary shift in brain imaging. It's early days. Scanning took 30 minutes, and the conditions were highly specific. But it's a proof of concept with massive potential. For now, it's just one beam of light. In the future, it could be the foundation of a global leap in how doctors see the a Laser Replace MRI Scans? One Bold Experiment Says Yes first appeared on Men's Journal on Jun 22, 2025
Yahoo
3 hours ago
- Yahoo
Mounjaro weight loss jab: All you need to know
GPs in England will be able to prescribe weight loss jabs for the first time on the NHS on Monday, as the health service begins its mass rollout. Some 220,000 people with the 'greatest need' are expected to receive Mounjaro, also known as tirzepatide and made by Lilly, through the NHS over the next three years. Here the PA news agency takes a look at the drug and the rollout. – How does tirzepatide work? Tirzepatide, or Mounjaro, is an antidiabetic drug which lowers blood sugar levels and slows down how quickly food is digested. It makes you feel fuller for longer and therefore less hungry. If the jab is recommended by a healthcare professional, those using it will need to eat a balanced, reduced-calorie diet and to exercise regularly while taking it, according to the NHS website. – Who might be eligible for the drug? In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of more than 40 who have at least four other health problems linked to obesity, such as type 2 diabetes; high blood pressure; heart disease; and obstructive sleep apnoea. It was previously only accessible to patients through a special weight loss service, to severely obese people who also suffer from a range of other health problems. Estimates suggest around 1.5 million people in the UK are already taking weight loss drugs, which may have been prescribed through specialist weight loss services or via private prescription. – How would it be administered? The drug is usually delivered through a self-administered weekly injection which a doctor or nurse will show patients how to use, the NHS website says. – Who cannot take tirzepatide? Mounjaro is not recommended for those who are pregnant or planning to get pregnant, breastfeeding or have certain health conditions, according to the NHS. For those taking the contraceptive pill and using tirzepatide, the NHS recommends using an additional method of contraception, such as a condom, for the first four weeks of treatment and for four weeks after each dose increase as the contraceptive pill may not be absorbed by the body during this time. – What are the potential side effects? Potential side effects of tirzepatide include nausea, vomiting, diarrhoea and constipation, according to the National Institute for Health and Care Excellence.
